Workflow
Earnings ESP
icon
Search documents
Coupang Set to Report Q4 Earnings: What's in Store for the Stock?
ZACKS· 2026-02-24 15:55
Key Takeaways The Zacks Consensus Estimate pegs CPNG's Q4 earnings at 2 cents per share, down 50% year over year.Coupang's developing offerings segment is expected to remain a drag on profitability in Q4.Coupang's elevated effective tax rate is expected to limit bottom-line conversion in the quarter.Coupang (CPNG) is scheduled to report its fourth-quarter 2025 results on Feb. 26.The Zacks Consensus Estimate for CPNG’s fourth-quarter 2025 revenues is currently pegged at $9.14 billion, indicating a 14.78% inc ...
BrightSpring to Post Q4 Earnings: What's in Store for the Stock?
ZACKS· 2026-02-24 14:35
Key Takeaways BTSG is set to report Q4 2025 results on Feb. 27, with revenues seen at $3.35B and EPS at 34 cents.Pharmacy Solutions likely drove growth on specialty scripts, generics and new drug launches.BTSG may post stronger margins, aided by mix gains, cost control and seasonal strength.BrightSpring Health Services, Inc. (BTSG) is scheduled to release fourth-quarter 2025 results on Feb. 27, before market open. In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 11.1 ...
Cheniere Energy to Report Q4 Earnings: What's in the Offing?
ZACKS· 2026-02-24 14:16
Key Takeaways LNG is set to report Q4 2025 earnings on Feb. 26, with EPS estimated at $3.83 per share.Revenues are expected to rise 16.66% year over year, driven by higher LNG sales and demand.Cheniere Energy has a 0.48% Earnings ESP and beat estimates in three of the last four quarters.Cheniere Energy, Inc. (LNG) is set to release fourth-quarter 2025 results on Feb. 26. The Zacks Consensus Estimate for earnings is pegged at $3.83 per share on revenues of $5.17 billion.Let us delve into the factors that are ...
Sempra Energy Set to Report Q4 Earnings: What's in the Offing?
ZACKS· 2026-02-24 14:00
Key Takeaways Sempra Energy is set to report Q4 results, with earnings seen down 24.7% year over year.New interim rates and rate-based growth likely supported regulated earnings and top-line performance.SRE is expected to face headwinds from mild weather, higher operating costs and increased interest expenses.Sempra Energy (SRE) is scheduled to release fourth-quarter 2025 results on Feb. 26, before market open. The company delivered an earnings surprise of 19.35% in the last reported quarter. Let’s discuss ...
Will BRP (DOO) Beat Estimates Again in Its Next Earnings Report?
ZACKS· 2026-02-23 18:10
Core Viewpoint - BRP Inc. is well-positioned to continue its earnings-beat streak in upcoming reports, having surpassed earnings estimates significantly in recent quarters [1]. Earnings Performance - In the most recent quarter, BRP reported earnings of $1.15 per share, exceeding the expected $0.88 per share by 30.68% [2]. - For the previous quarter, BRP's actual earnings were $0.67 per share, compared to the consensus estimate of $0.33 per share, resulting in a surprise of 103.03% [2]. Earnings Estimates and Predictions - Recent estimates for BRP have been increasing, with a positive Earnings ESP of +0.17%, indicating bullish sentiment among analysts regarding the company's earnings prospects [5][8]. - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) suggests a high likelihood of another earnings beat, with historical data showing that such combinations lead to positive surprises nearly 70% of the time [6][8]. Earnings ESP Explanation - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions, which may be more accurate than earlier predictions [7]. - A negative Earnings ESP does not necessarily indicate an earnings miss but can reduce the predictive power of the metric [8].
Will Climb Global (CLMB) Beat Estimates Again in Its Next Earnings Report?
ZACKS· 2026-02-23 18:10
Core Insights - Climb Global Solutions (CLMB) has a strong history of beating earnings estimates and is well-positioned for future earnings success [1] Earnings Performance - Climb Global has consistently surpassed earnings estimates, achieving an average beat of 34.18% over the last two quarters [2] - In the most recent quarter, the company reported earnings of $1.31 per share, exceeding the Zacks Consensus Estimate of $1.15 per share by 13.91% [3] - In the previous quarter, Climb Global's earnings were $1.39 per share against an expected $0.90 per share, resulting in a surprise of 54.44% [3] Earnings Estimates and Predictions - Recent earnings estimates for Climb Global have been revised upward, indicating positive sentiment among analysts [5] - The Zacks Earnings ESP for Climb Global is currently +5.56%, suggesting bullish expectations for the company's earnings [8] - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) indicates a high likelihood of another earnings beat [8] Predictive Metrics - Stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have a nearly 70% chance of producing a positive surprise [6] - The Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, reflecting the latest analyst revisions [7]
Astronics Q4 Earnings Loom: Should You Buy the Stock Ahead of Results?
ZACKS· 2026-02-23 18:06
Key Takeaways ATRO's Q4 earnings are projected to rise 31.3% from the prior year quarter.Astronics' Aerospace unit, about 90% of revenues, likely gained on air travel demand.ATRO shares have surged 291.3% in a year, outpacing its industry and the sector.Astronics Corporation (ATRO) is slated to release fourth-quarter 2025 results on Feb. 24, 2026, after market close.The Zacks Consensus Estimate for earnings is pegged at 63 cents per share, suggesting an improvement of 31.3% from the prior-year quarter’s rep ...
Should You Buy ANI Pharmaceuticals Stock Before Q4 Earnings?
ZACKS· 2026-02-23 16:35
Key Takeaways ANI Pharmaceuticals reports Q4 2025 earnings Feb. 27, with sales seen at $233M and EPS at $1.99.ANIP's Cortrophin Gel sales are expected at $114M, driven by 88% year-over-year growth.ANIP trades at 1.98x P/S, below the industry's 2.50x, with growth led by rare disease drugs.ANI Pharmaceuticals (ANIP) is set to report fourth-quarter and full-year 2025 earningson Feb. 27, before the opening bell. The Zacks Consensus Estimate for the quarter’s sales and earnings is pegged at $233 million and $1.9 ...
Venture Global (VG) Reports Next Week: What Awaits?
ZACKS· 2026-02-23 16:01
Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when Venture Global (VG) reports results for the quarter ended December 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on ...
Limbach (LMB) Earnings Expected to Grow: Should You Buy?
ZACKS· 2026-02-23 16:01
Limbach (LMB) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on March 2. On t ...